S&P 500   3,122.70 (-0.18%)
DOW   26,998.00 (-0.31%)
QQQ   216.44 (+0.50%)
AAPL   291.63 (+1.23%)
FB   197.64 (+0.44%)
MSFT   169.52 (+0.86%)
AMZN   1,977.85 (+0.26%)
CGC   19.71 (+0.46%)
NVDA   267.10 (+1.93%)
BABA   208.73 (+1.52%)
MU   52.14 (+0.08%)
GE   10.88 (-3.89%)
TSLA   785.06 (-1.86%)
AMD   47.52 (-0.11%)
T   37.18 (-0.48%)
ACB   1.51 (-0.66%)
F   7.22 (-0.14%)
NFLX   377.86 (+4.93%)
BAC   30.61 (-1.51%)
DIS   123.05 (-4.01%)
GILD   74.50 (+6.28%)
S&P 500   3,122.70 (-0.18%)
DOW   26,998.00 (-0.31%)
QQQ   216.44 (+0.50%)
AAPL   291.63 (+1.23%)
FB   197.64 (+0.44%)
MSFT   169.52 (+0.86%)
AMZN   1,977.85 (+0.26%)
CGC   19.71 (+0.46%)
NVDA   267.10 (+1.93%)
BABA   208.73 (+1.52%)
MU   52.14 (+0.08%)
GE   10.88 (-3.89%)
TSLA   785.06 (-1.86%)
AMD   47.52 (-0.11%)
T   37.18 (-0.48%)
ACB   1.51 (-0.66%)
F   7.22 (-0.14%)
NFLX   377.86 (+4.93%)
BAC   30.61 (-1.51%)
DIS   123.05 (-4.01%)
GILD   74.50 (+6.28%)
S&P 500   3,122.70 (-0.18%)
DOW   26,998.00 (-0.31%)
QQQ   216.44 (+0.50%)
AAPL   291.63 (+1.23%)
FB   197.64 (+0.44%)
MSFT   169.52 (+0.86%)
AMZN   1,977.85 (+0.26%)
CGC   19.71 (+0.46%)
NVDA   267.10 (+1.93%)
BABA   208.73 (+1.52%)
MU   52.14 (+0.08%)
GE   10.88 (-3.89%)
TSLA   785.06 (-1.86%)
AMD   47.52 (-0.11%)
T   37.18 (-0.48%)
ACB   1.51 (-0.66%)
F   7.22 (-0.14%)
NFLX   377.86 (+4.93%)
BAC   30.61 (-1.51%)
DIS   123.05 (-4.01%)
GILD   74.50 (+6.28%)
S&P 500   3,122.70 (-0.18%)
DOW   26,998.00 (-0.31%)
QQQ   216.44 (+0.50%)
AAPL   291.63 (+1.23%)
FB   197.64 (+0.44%)
MSFT   169.52 (+0.86%)
AMZN   1,977.85 (+0.26%)
CGC   19.71 (+0.46%)
NVDA   267.10 (+1.93%)
BABA   208.73 (+1.52%)
MU   52.14 (+0.08%)
GE   10.88 (-3.89%)
TSLA   785.06 (-1.86%)
AMD   47.52 (-0.11%)
T   37.18 (-0.48%)
ACB   1.51 (-0.66%)
F   7.22 (-0.14%)
NFLX   377.86 (+4.93%)
BAC   30.61 (-1.51%)
DIS   123.05 (-4.01%)
GILD   74.50 (+6.28%)
Log in

Vistagen Therapeutics SEC Filings & 10K Form (NASDAQ:VTGN)

$0.60
-0.03 (-4.76 %)
(As of 02/26/2020 03:14 PM ET)
Today's Range
$0.60
Now: $0.60
$0.64
50-Day Range
$0.63
MA: $0.71
$0.80
52-Week Range
$0.29
Now: $0.60
$1.49
Volume4,480 shs
Average Volume375,601 shs
Market Capitalization$28.78 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.43

SEC Filings

Vistagen Therapeutics (NASDAQ:VTGN) SEC Filings

DateFilerForm TypeView
02/13/2020
3:39 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2020
11:12 AM
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Vistagen Therapeutics (Subject)
Form SC 13G/A
01/31/2020
4:25 PM
Vistagen Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/31/2020
4:22 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2020
5:02 AM
Lincoln Park Capital Fund, LLC (Filed by)
Vistagen Therapeutics (Subject)
Form SC 13G
01/24/2020
4:01 PM
Vistagen Therapeutics (Filer)
Form 424B5
12/27/2019
3:05 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
4:14 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2019
6:52 PM
SNODGRASS H. RALPH (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
6:46 AM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
4:02 PM
DOTSON JERROLD DUANE (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
MCPARTLAND MARK A. (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
Smith Mark Alan (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
SNODGRASS H. RALPH (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:00 PM
Underdown Brian J. (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:00 PM
GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:00 PM
SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2019
11:15 PM
Vistagen Therapeutics (Filer)
Form EFFECT
09/30/2019
9:44 PM
Vistagen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/30/2019
4:31 PM
Vistagen Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/25/2019
3:03 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
3:55 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:37 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
3:06 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
3:11 PM
Vistagen Therapeutics (Filer)
Form DEFA14A
07/25/2019
3:08 PM
Vistagen Therapeutics (Filer)
Form DEFA14A
07/23/2019
4:12 PM
Vistagen Therapeutics (Filer)
Form DEF 14A
07/23/2019
3:31 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
4:20 PM
Vistagen Therapeutics (Filer)
Form PRE 14A
06/25/2019
3:17 PM
Vistagen Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/21/2019
4:00 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2019
3:20 PM
SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:18 PM
GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:17 PM
Underdown Brian J. (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:12 PM
Smith Mark Alan (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:10 PM
MCPARTLAND MARK A. (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:09 PM
DOTSON JERROLD DUANE (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:07 PM
Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
4:22 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
3:10 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
4:22 PM
SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
4:12 PM
SNODGRASS H. RALPH (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:50 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
3:15 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
3:36 PM
Vistagen Therapeutics (Filer)
Form 424B5
02/25/2019
3:40 PM
Vistagen Therapeutics (Filer)
Form 424B5
02/12/2019
3:34 PM
Vistagen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/08/2019
1:01 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Vistagen Therapeutics (Subject)
Form SC 13G/A
01/30/2019
3:05 PM
SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
3:29 PM
Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
3:16 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2019
8:55 PM
Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
8:55 PM
Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
8:50 PM
Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2019
4:30 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
12:58 PM
SABBY MANAGEMENT, LLC (Filed by)
Vistagen Therapeutics (Subject)
Form SC 13G/A
12/17/2018
9:25 AM
Vistagen Therapeutics (Filer)
Form CT ORDER
12/13/2018
4:00 PM
Vistagen Therapeutics (Filer)
Form 8-K/A
10/30/2018
3:37 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:30 PM
Vistagen Therapeutics (Filer)
Form 10-Q/A
10/29/2018
3:16 PM
Vistagen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2018
3:21 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2018
1:04 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2018
10:30 AM
Vistagen Therapeutics (Filer)
Form CT ORDER
09/21/2018
2:43 PM
Vistagen Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
09/18/2018
4:30 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2018
4:23 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2018
4:28 PM
Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:27 PM
SNODGRASS H. RALPH (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:26 PM
SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:25 PM
DOTSON JERROLD DUANE (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:24 PM
GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:23 PM
MCPARTLAND MARK A. (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:22 PM
Underdown Brian J. (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:21 PM
Smith Mark Alan (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2018
1:32 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
4:00 PM
GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
3:57 PM
SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
3:55 PM
Underdown Brian J. (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
3:54 PM
Smith Mark Alan (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
3:53 PM
MCPARTLAND MARK A. (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
3:52 PM
SNODGRASS H. RALPH (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
3:38 PM
DOTSON JERROLD DUANE (Reporting)
Vistagen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2018
3:05 PM
Vistagen Therapeutics (Filer)
Form DEFA14A
07/27/2018
3:03 PM
Vistagen Therapeutics (Filer)
Form DEF 14A
06/27/2018
1:09 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2018
3:56 PM
Vistagen Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/13/2018
3:18 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
3:05 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2018
3:15 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2018
4:13 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2018
3:32 PM
Vistagen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2018
8:27 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2018
11:39 AM
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Vistagen Therapeutics (Subject)
Form SC 13G/A
02/13/2018
5:37 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Vistagen Therapeutics (Subject)
Form SC 13G/A
02/12/2018
8:55 PM
Vistagen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2018
3:32 PM
Vistagen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/09/2018
10:47 AM
CVI Investments, Inc. (Filed by)
Vistagen Therapeutics (Subject)
Form SC 13G/A
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel